SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

EBITDA Summary of SynBiotic SE

  • SynBiotic SE's latest annual EBITDA in 2023 was -7.12 Million EUR , down -4.4% from previous year.
  • SynBiotic SE's latest quarterly EBITDA in 2023 FY was N/A , down -4.4% from previous quarter.
  • SynBiotic SE reported an annual EBITDA of -24.17 Million EUR in 2022, down -23.62% from previous year.
  • SynBiotic SE reported an annual EBITDA of -10.61 Million EUR in 2021, down -719.09% from previous year.
  • SynBiotic SE reported a quarterly EBITDA of - EUR for 2023 Q2, down 0.0% from previous quarter.
  • SynBiotic SE reported a quarterly EBITDA of -1.14 Million EUR for 2022 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of SynBiotic SE (2023 - 2018)

Historical Annual EBITDA of SynBiotic SE (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -7.12 Million EUR -4.4%
2022 -24.17 Million EUR -23.62%
2021 -10.61 Million EUR -719.09%
2020 -716.12 Thousand EUR -4389.6%
2019 -1.00 EUR -1533.7%
2018 -822.00 EUR 0.0%

Peer EBITDA Comparison of SynBiotic SE

Name EBITDA EBITDA Difference
MPH Health Care AG 33.31 Million EUR 121.38%
Apontis Pharma AG -12.94 Million EUR 44.962%
Dermapharm Holding SE 277.29 Million EUR 102.569%
Evotec SE 7.82 Million EUR 191.047%
MERCK Kommanditgesellschaft auf Aktien 5.52 Billion EUR 100.129%
PharmaSGP Holding SE 35.86 Million EUR 119.858%